Works matching DE "TRASTUZUMAB"

Results: 2978
    1
    2
    3

    Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER).

    Published in:
    Oncologist, 2025, v. 30, n. 7, p. 1, doi. 10.1093/oncolo/oyaf200
    By:
    • Angelis, Carmine De;
    • Pagliuca, Martina;
    • Magnolfi, Emanuela;
    • Mansutti, Mauro;
    • Ballatore, Zelmira;
    • Laurentiis, Michelino De;
    • Bordonaro, Roberto;
    • Leonardi, Vita;
    • Bruzzese, Dario;
    • Caputo, Roberta;
    • Mosconi, Anna Maria;
    • Cinieri, Saverio;
    • Fabi, Alessandra;
    • Mastro, Lucia Del;
    • Puglisi, Fabio;
    • Placido, Sabino De;
    • Giuliano, Mario;
    • Arpino, Grazia
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab.

    Published in:
    Pathology & Oncology Research, 2015, v. 21, n. 2, p. 273, doi. 10.1007/s12253-014-9818-2
    By:
    • Pavlakis, Kitty;
    • Bobos, Mattheos;
    • Batistatou, Anna;
    • Kotoula, Vassiliki;
    • Eleftheraki, Anastasia;
    • Stofas, Anastasios;
    • Timotheadou, Eleni;
    • Pentheroudakis, George;
    • Psyrri, Amanda;
    • Koutras, Angelos;
    • Pectasides, Dimitrios;
    • Papakostas, Pavlos;
    • Razis, Evangelia;
    • Christodoulou, Christos;
    • Kalogeras, Konstantine;
    • Fountzilas, George
    Publication type:
    Article
    20
    21
    22
    23
    24

    Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 3, p. 719, doi. 10.1007/s00432-021-03651-1
    By:
    • Sibert, Nora Tabea;
    • Wesselmann, Simone;
    • Breidenbach, Clara;
    • Blohmer, Jens;
    • Brückner, Barbara;
    • Gebauer, Gerhard;
    • dos Santos Guilherme, Marina;
    • Hartkopf, Andreas;
    • Lindner, Christoph;
    • Peschel, Susanne;
    • Rieger, Lorenz;
    • Schad, Friedemann;
    • Strecker, Paul;
    • Ferencz, Julia;
    • Dieng, Sebastian;
    • Inwald, Elisabeth C.;
    • Kowalski, Christoph;
    • Ortmann, Olaf
    Publication type:
    Article
    25
    26
    27

    HER2 testing in gastric cancer: results of a German expert meeting.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 5, p. 835, doi. 10.1007/s00432-017-2374-x
    By:
    • Lordick, Florian;
    • Al-Batran, Salah-Eddin;
    • Dietel, Manfred;
    • Gaiser, Timo;
    • Hofheinz, Ralf-Dieter;
    • Kirchner, Thomas;
    • Kreipe, Hans;
    • Lorenzen, Sylvie;
    • Möhler, Markus;
    • Quaas, Alexander;
    • Röcken, Christoph;
    • Rüschoff, Josef;
    • Tannapfel, Andrea;
    • Thuss-Patience, Peter;
    • Baretton, Gustavo
    Publication type:
    Article
    28
    29

    Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 669, doi. 10.1007/s00432-015-2033-z
    By:
    • Arpino, Grazia;
    • Michelotti, Andrea;
    • Truini, Mauro;
    • Montemurro, Filippo;
    • Russo, Stefania;
    • Palumbo, Raffaella;
    • Zamagni, Claudio;
    • Latorre, Agnese;
    • Bruzzese, Dario;
    • Riccardi, Ferdinando;
    • De Laurentiis, Michelino;
    • Beano, Alessandra;
    • Biganzoli, Laura;
    • Zaniboni, Alberto;
    • Laudadio, Lucio;
    • Malagoli, Maria;
    • Bilancia, Domenico;
    • Schettini, Francesco;
    • Giuliano, Mario;
    • Cazzaniga, Marina
    Publication type:
    Article
    30

    Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer.

    Published in:
    Molecules, 2020, v. 25, n. 5, p. 1025, doi. 10.3390/molecules25051025
    By:
    • Cędrowska, Edyta;
    • Pruszyński, Marek;
    • Gawęda, Weronika;
    • Żuk, Michał;
    • Krysiński, Paweł;
    • Bruchertseifer, Frank;
    • Morgenstern, Alfred;
    • Karageorgou, Maria-Argyro;
    • Bouziotis, Penelope;
    • Bilewicz, Aleksander;
    • Luciani, Paola;
    • Brambilla, Davide
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    LATEST NEWS.

    Published in:
    ONS Voice, 2020, v. 35, n. 1, p. 12
    By:
    • Becze, Elisa
    Publication type:
    Article
    42
    43
    44

    Intricacies in the Preparation of Patient Doses of [<sup>177</sup>Lu]Lu-Rituximab and [<sup>177</sup>Lu]Lu-Trastuzumab Using Low Specific Activity [<sup>177</sup>Lu]LuCl<sub>3</sub>: Methodological Aspects.

    Published in:
    Molecular Imaging & Biology, 2024, v. 26, n. 1, p. 61, doi. 10.1007/s11307-023-01846-1
    By:
    • Chakraborty, Avik;
    • Mitra, Arpit;
    • Sahu, Sudeep;
    • Tawate, Megha;
    • Lad, Sangita;
    • Kamaldeep;
    • Rakshit, Sutapa;
    • Upadhye Bannore, Trupti;
    • Gaikwad, Sujay;
    • Dhotre, Geetanjali;
    • Ray, Mukti Kanta;
    • Damle, Archana;
    • Basu, Sandip;
    • Banerjee, Sharmila
    Publication type:
    Article
    45
    46
    47
    48
    49

    The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00652-4
    By:
    • Johnson, Kai C. C.;
    • Ni, Ai;
    • Quiroga, Dionisia;
    • Pariser, Ashley C.;
    • Sudheendra, Preeti K.;
    • Williams, Nicole O.;
    • Sardesai, Sagar D.;
    • Cherian, Mathew;
    • Stover, Daniel G.;
    • Gatti-Mays, Margaret;
    • Ramaswamy, Bhuvaneswari;
    • Lustberg, Maryam;
    • Jhawar, Sachin;
    • Skoracki, Roman;
    • Wesolowski, Robert
    Publication type:
    Article
    50